about
Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationRandomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.Review of therapeutic advances in diabetic retinopathy.Surgical management of diabetic retinopathy.Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.Progressive changes in diabetics and their management.Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation.Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.Surgical treatment for diabetic vitreoretinal diseases: a review.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Outcomes of transconjunctival sutureless 27-gauge micro-incision vitrectomy surgery in diabetic vitreous haemorrhage.Axial length and intraoperative posterior vitreous detachment as predictive factors for surgical outcomes of diabetic vitrectomy.Comparison of clinical outcome between 23-G and 25-G vitrectomy in diabetic patients.The effect of partial vitrectomy on blood-ocular barrier function in the rabbit.Intraocular surgery in a large diabetes patient population: risk factors and surgical results.Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease.Retinal oximetry using intravitreal illumination.
P2860
Q31081886-19382CBF-5CC7-49E9-BE34-6BB26D39293BQ34440571-4287F567-3485-48C5-85E8-571D3AAE2338Q34475449-8447F508-82D1-4A26-A3C9-F2404F8E5828Q35067106-45BDCDEF-B370-4037-8939-0C2BD862E62AQ35592354-CC08FC14-06B1-4B6D-9EC8-C14CD9E87961Q36320419-7B608332-ADF6-4CA9-8F0C-C7F3EBFE1BB2Q36673663-D72E9E0C-BFD9-4AF2-9291-C5EE0D409D8CQ37477129-1DA92BF4-B063-4DC0-A3F2-86C08774EFE0Q37700513-DF51B749-2AA3-4A23-AF05-AE1B3E4975E8Q38174330-9395B00F-F9FE-4D64-BFFE-A3E20A66B721Q38793330-7237B563-00CE-4A34-B965-C78A2540280BQ39103248-0C29F984-34F7-4A66-B5AA-3E430304210EQ42372149-62B6ACAA-99EE-4DA9-95F8-B99D69361D0EQ43193901-BAC16A66-3FEC-405C-AE13-6C257A7E0FC0Q43272479-915FEBD9-9B91-476C-8FB6-23F9FE3D80D1Q43929188-3E0BB419-01B1-4D16-BE11-27048E2D1450Q44920544-2DD80D7D-915C-4DC4-B6DF-F11EBE7E8CEAQ50031588-88DF0A7A-0886-4DD6-BDA7-21E0D73878E2Q51793243-66D695BD-5542-45BB-BA65-BAAEB711D372
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Vitrectomy in the management of diabetic retinopathy.
@ast
Vitrectomy in the management of diabetic retinopathy.
@en
type
label
Vitrectomy in the management of diabetic retinopathy.
@ast
Vitrectomy in the management of diabetic retinopathy.
@en
prefLabel
Vitrectomy in the management of diabetic retinopathy.
@ast
Vitrectomy in the management of diabetic retinopathy.
@en
P1476
Vitrectomy in the management of diabetic retinopathy.
@en
P2093
Flynn HW Jr
P304
P356
10.1016/S0039-6257(99)00036-3
P577
1999-05-01T00:00:00Z